These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 23299929

  • 1. The impact of recipient HLA-Cw and donor killer immunoglobulin-like receptor genotyping on the outcome of patients receiving HLA-matched sibling donor hematopoietic stem cell transplantation for myeloid malignancies.
    Wang H, He Y, Zhai WJ, Wang M, Zhou Z, Zhao YX, Feng SZ, Han MZ.
    Swiss Med Wkly; 2013; 143():w13717. PubMed ID: 23299929
    [Abstract] [Full Text] [Related]

  • 2. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
    Zhou H, Bao X, Wu X, Tang X, Wang M, Wu D, He J.
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
    Sahin U, Dalva K, Gungor F, Ustun C, Beksac M.
    Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
    [Abstract] [Full Text] [Related]

  • 5. The effect of killer cell immunoglobulin-like receptor genotype on outcome of hematopoietic stem cell transplantation from matched sibling.
    Elfishawi SM, Mossallam GI, El-Fattah RA, El-Haddad A, Kamel AM.
    Hum Immunol; 2017 Nov; 78(11-12):684-691. PubMed ID: 28993188
    [Abstract] [Full Text] [Related]

  • 6. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM, Kemp TJ, Dharmani-Khan P, Lewis V, Tripathi G, Rajalingam R, Daly A, Berka N, Storek J, Masood Khan F.
    PLoS One; 2016 Nov; 11(6):e0158242. PubMed ID: 27341514
    [Abstract] [Full Text] [Related]

  • 7. Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptors.
    Sobecks RM, Ball EJ, Maciejewski JP, Rybicki LA, Brown S, Kalaycio M, Pohlman B, Andresen S, Theil KS, Dean R, Bolwell BJ.
    Bone Marrow Transplant; 2007 Apr; 39(7):417-24. PubMed ID: 17310134
    [Abstract] [Full Text] [Related]

  • 8. Role of killer immunoglobulin-like receptor-ligand interactions in human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.
    Kanga U, Mourya M, Seth T, George J, Sood P, Sharma R, Saxena A, Mehra NK.
    Transplant Proc; 2012 May; 44(4):919-21. PubMed ID: 22564585
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
    Khanuntong S, Kuptawintu P, Upaisilpsathaporn K, Poolchareon A, Bunworasate U, Hirankarn N.
    HLA; 2016 Jun; 87(6):422-31. PubMed ID: 27273744
    [Abstract] [Full Text] [Related]

  • 11. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.
    McQueen KL, Dorighi KM, Guethlein LA, Wong R, Sanjanwala B, Parham P.
    Hum Immunol; 2007 May; 68(5):309-23. PubMed ID: 17462498
    [Abstract] [Full Text] [Related]

  • 12. [Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].
    Wang H, Zhai WJ, Wang HH, He Y, Zhou Z, Zhao YX, Zhai WH, Zhang RL, Wang M, Feng SZ, Han MZ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):533-7. PubMed ID: 19968064
    [Abstract] [Full Text] [Related]

  • 13. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
    Clausen J, Kircher B, Auberger J, Schumacher P, Ulmer H, Hetzenauer G, Wolf D, Gastl G, Nachbaur D.
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):273-80. PubMed ID: 19857587
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
    Hoseinian SA, Jafari D, Mahmoodi M, Alimoghaddam K, Ostadali M, Talebzadeh Bonakdar A, Foma AM, Yekaninejad MS, Amirzargar AA.
    Turk J Med Sci; 2018 Aug 16; 48(4):794-804. PubMed ID: 30119155
    [Abstract] [Full Text] [Related]

  • 16. Impact of incompatible killer cell immunoglobulin-like receptor and its ligand on the outcome of haploidentical bone marrow transplantation.
    Duan LN, Han HX, Liu J, Yan HM, Zhu L, Xue M, Ding L, Zhu PY, Wang HX, Ji SQ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug 16; 15(4):809-15. PubMed ID: 17708809
    [Abstract] [Full Text] [Related]

  • 17. KIR2DS4 and Its Variant KIR1D Are Associated with Acute Graft-versus-Host Disease, Cytomegalovirus, and Overall Survival after Sibling-Related HLA-Matched Transplantation in Patients with Donors with KIR Gene Haplotype A.
    Wu X, Yao Y, Bao X, Zhou H, Tang X, Han Y, Ma X, Liu Y, Chen J, Zhou H, Jing S, Gu B, Xu Y, Sun A, He J, Wu D.
    Biol Blood Marrow Transplant; 2016 Feb 16; 22(2):220-225. PubMed ID: 26476204
    [Abstract] [Full Text] [Related]

  • 18. Synergistic effect of KIR ligands missing and cytomegalovirus reactivation in improving outcomes of haematopoietic stem cell transplantation from HLA-matched sibling donor for treatment of myeloid malignancies.
    Cardozo DM, Marangon AV, da Silva RF, Aranha FJP, Visentainer JEL, Bonon SHA, Costa SCB, Miranda ECM, de Souza CA, Guimarães F.
    Hum Immunol; 2016 Oct 16; 77(10):861-868. PubMed ID: 27394130
    [Abstract] [Full Text] [Related]

  • 19. Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community.
    Gaafar A, Sheereen A, Almohareb F, Eldali A, Chaudhri N, Mohamed SY, Hanbali A, Shaheen M, Alfraih F, El Fakih R, Iqneibi A, Youniss R, Elhassan T, Hashmi S, Aljurf M, Alhussein K.
    Bone Marrow Transplant; 2018 Sep 16; 53(9):1170-1179. PubMed ID: 29549293
    [Abstract] [Full Text] [Related]

  • 20. [Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation].
    Liang ZY, Ren HY, Cen XN, Qiu ZX, Wang LH, Ou JP, Li Y, Wang MJ, Wang WS, Xu WL, Dong YJ, Yin Y, Sun YH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb 16; 21(1):155-60. PubMed ID: 23484711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.